Jacobs Levy Equity Management’s Oyster Point Pharma, Inc. Common Stock OYST Stock Holding History

Jacobs Levy Equity Management’s Portfolio OYST Stock Details OYST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-20,537	Closed	-$239K	–	1129
2022 Q1	$239K	Buy	+20,537	New	+$244K	﹤0.01%	946
2021 Q4	–	Sell	-31,204	Closed	-$370K	–	1118
2021 Q3	$370K	Buy	+31,204	New	+$454K	﹤0.01%	904
2021 Q2	–	Sell	-19,830	Closed	-$362K	–	1146
2021 Q1	$362K	Buy	+19,830	New	+$416K	﹤0.01%	907

Other funds holding OYST

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

IFA

Invus Financial Advisors New York $89.2M AUM 10.79% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

KKRC

Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

TAM

Telemark Asset Management Boston, Massachusetts $1.08B AUM 70.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

Jacobs Levy Equity Management's OYST Position: Q2 2022 in Review

Jacobs Levy Equity Management sold out of Oyster Point Pharma, Inc. Common Stock (OYST) in Q2 2022, closing a stake of 20,537 shares — an estimated $239K sold.

Jacobs Levy Equity Management first reported a position in OYST in Q1 2021 and held it in 3 quarters. The position peaked at $370K in Q3 2021. 61 funds tracked by Wall St. Rank hold OYST as of Q2 2022.

Jacobs Levy Equity Management reported no remaining Oyster Point Pharma, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
Jacobs Levy Equity Management sold 20,537 Oyster Point Pharma, Inc. Common Stock shares in Q2 2022, an estimated $239K.
Jacobs Levy Equity Management first reported a position in Oyster Point Pharma, Inc. Common Stock in Q1 2021 and held it in 3 quarters.
Jacobs Levy Equity Management's Oyster Point Pharma, Inc. Common Stock position peaked at $370K in Q3 2021.
61 funds tracked by Wall St. Rank held Oyster Point Pharma, Inc. Common Stock as of Q2 2022.

Based on Jacobs Levy Equity Management's 13F filing for Q2 2022, filed 15 Aug 2022.